Criteria for the evaluation of cytostatic chemotherapy
Dold, U.
International Journal of Clinical Pharmacology and Biopharmacy 16(2): 68-71
1978
ISSN/ISBN: 0340-0026 PMID: 631973 Document Number: 126681
The evaluation of cytostatic chemotherapy is difficult because the criteria are multivarious and the system for testing is complex. The clinical trial only is a reliable method. But the clnical trial require a cooperative study and a cooperative study is very expansive. It is necessary to search for methods less expensive but statistical sufficient.
Document emailed within 1 workday
Related Documents
Mikami, K.; Nakagawa, S.; Sugimoto, K.; Nomoto, T.; Urano, S.; Watanabe, H.; Iwamoto, N.; Yamazaki, S.; Hiratake, Y.; Maegawa, M. 1997: Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria Hinyokika Kiyo. Acta Urologica Japonica 43(8): 561-566Dold, U.; Engel, J. 1970: Cytostatic chemotherapy of bronchial carcinoma Der Internist 11(9): 343-349
Heim, M.E. 1986: Adjuvant parenteral nutrition in cytostatic chemotherapy Infusionstherapie und Klinische Ernahrung 13(3): 115-121
Meuthen, I.; Mödder, B. 1981: Advanced non-Hodgkin lymphomas in adults. Cytostatic chemotherapy Die Medizinische Welt 32(41): 1545-1547
Tabona, M.V. 1990: An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy European Journal of Cancer 26(Suppl 1): S37-S44
Stepankovskaia, G.K.; Milianovskiĭ, A.I.; Frolova, G.D. 1977: Determination of sensitivity to cytostatic preparations during chemotherapy of malignant tumors Vrachebnoe Delo 2: 109-112
Kusaba, H.; Saijo, N. 2000: A summary report of response evaluation criteria in solid tumors (RECIST criteria) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(1): 1-5
Brun, F.; Brunner, K.W. 1971: Delayed hypersensitivity reaction to 2,4-dinitrochlorobenzol in cancer patients undergoing cytostatic chemotherapy Schweizerische Medizinische Wochenschrift 101(34): 1235-1243
Ludwig, H.; Fritz, E. 1981: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells Anticancer Research 1(6): 329-334
Feinleib, M.; Labarthe, D.; Shekelle, R.; Kuller, L. 1974: Criteria for evaluation of automated blood pressure measuring devices for use in hypertensive screening programs. A report of the Committee on Criteria and Methods of the Council on Epidemiology, American Heart Association Circulation 49(3 Suppl): 6-11
Kondo, T. 1971: Evaluation of tuberculosis control on regional level. I. Establishment of criteria for the evaluation of tuberculosis control. II. Establishment of criteria by combining the indices for the evaluation of tuberculosis control Kekkaku: 46(9): 351-355
Ardizzi, A.; Barberis, S.; Galietti, F.; Ghione, G.L.; Giorgis, G.E.; Massaglia, G.M. 1985: Chemotherapy criteria in tuberculous meningitis Panminerva Medica 27(4): 201-207
Smith, I.E. 1990: A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S19-S23
Nishiyama, M.; Toge, T. 1997: Selection of adjuvant chemotherapy for gastric cancer using objective criteria Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24 Suppl. 1: 232-238
Gebarowska, E.; Zabel, M.; Majewski, A.; Kołodziej, J. 1999: Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells Folia Histochemica et Cytobiologica 37(2): 135-136
Giełdanowski, J.; Steuden, W. 1981: Screening system for the evaluation of preparations with potential cytostatic and immunotropic activity. III. Derivatives of hexahydrochromate Archivum Immunologiae et Therapiae Experimentalis 29(2): 267-271
Petrashenko, A.I. 1985: Immunological criteria of the indications for performing prophylactic chemotherapy in persons with a hyperergic Mantoux test Vrachebnoe Delo 7: 31-33
Iablons'ka, S.V.; Filins'ka, O.M.; Ostrovs'ka, H.V.; Rybal'chenko, V.K. 2009: Evaluation of hepatotoxicity of novel maleimide derivative with cytostatic activity and its effect on peroxidation process and antioxidant system in the liver Ukrains'kyi Biokhimichnyi Zhurnal 81(5): 83-92
Kodama, F.; Mohri, H.; Motomura, S.; Fukawa, H.; Tanabe, J.; Koharasawa, H.; Kanamori, H.; Hashimoto, Y.; Harano, H.; Sakai, R.; Tomita, N.; Fujimaki, K.; Takemura, S.; Hattori, M. 2002: Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 273-279
Gómez, J.B.; Díaz, M.A.; Jerez, M.L. 1973: Tertiary hyperthyroidism. Criteria of evaluation Revista de Medicina de la Universidad de Navarra 17(3): 231-239